A quick access to CF3-containing functionalized benzofuranyl, benzothiophene and indolyl heterocycles under catalyst-free conditions.

A catalyst-free one-pot synthetic protocol is presented for the preparation of CF3-containing benzofuran, indolin, and benzothiophene derivatives using readily available aromatic aldehydes and ketones. 2-Bromo-3,3,3-trifluoropropene was employed as a non-corrosive and environmentally benign trifluoromethylacetylene synthon for incorporation of the CF3 group. The reaction proceeds via the formation of a suitably substituted 4,4,4-trifluoro-1-phenylbut-2-yn-1-ol intermediate, which undergoes 5-exo-dig cyclization, resulting in an exocyclic double bond with Z-configuration. The synthetic utility, substrate scope, tolerance to broader substrates are also presented.

Synthetic approaches to FDA approved drugs for asthma and COPD from 1969 to 2020.

Respiratory infections resulting from pulmonary inflammation emerging as a leading cause of death worldwide. However, only twenty-seven new drugs were approved in the last five decades. In this review, we presented synthetic approaches for twenty-seven FDA-approved medications used to treat asthma and chronic obstructive pulmonary diseases (COPD), along with their mode of action.